Published in Mediators Inflamm on June 12, 2013
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol (2014) 1.13
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care (2016) 1.04
Obesity and cancer pathogenesis. Ann N Y Acad Sci (2014) 0.93
Non-alcoholic fatty liver disease, diet and gut microbiota. EXCLI J (2014) 0.81
Zinc treatment ameliorates diarrhea and intestinal inflammation in undernourished rats. BMC Gastroenterol (2014) 0.80
Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids. J Diabetes Res (2015) 0.79
Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients. Am J Transl Res (2016) 0.78
Xenobiotics: Interaction with the Intestinal Microflora. ILAR J (2015) 0.78
Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am J Physiol Gastrointest Liver Physiol (2016) 0.78
Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol (2015) 0.78
Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. PLoS One (2016) 0.78
The effect of Nigella sativa on inflammation-induced myocardial fibrosis in male rats. Res Pharm Sci (2017) 0.78
Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling. Acta Pharmacol Sin (2016) 0.77
Advanced application of porcine intramuscular adipocytes for evaluating anti-adipogenic and anti-inflammatory activities of immunobiotics. PLoS One (2015) 0.76
Metabolomics of ApcMin/+ mice genetically susceptible to intestinal cancer. BMC Syst Biol (2014) 0.76
Changes of the Intestinal Microbiome-Host Homeostasis in HIV-Infected Individuals - A Focus on the Bacterial Gut Microbiome. Eur J Microbiol Immunol (Bp) (2017) 0.75
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Diversity of the human intestinal microbial flora. Science (2005) 49.64
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Inflammation and metabolic disorders. Nature (2006) 33.33
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
Obesity as a medical problem. Nature (2000) 15.12
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab (2005) 13.91
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science (2010) 12.54
IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A (2007) 9.71
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature (2009) 8.71
Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A (2009) 8.25
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
Mechanisms for insulin resistance: common threads and missing links. Cell (2012) 6.85
Inflammasomes in health and disease. Nature (2012) 6.75
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 6.61
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature (2012) 6.37
Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) (2009) 6.12
Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 5.83
Honor thy symbionts. Proc Natl Acad Sci U S A (2003) 5.72
Retracted Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes (2007) 5.67
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61
S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A (1992) 5.37
LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol (2005) 5.25
Transcriptional control of the inflammatory response. Nat Rev Immunol (2009) 5.20
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest (2000) 4.60
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A (2008) 4.45
Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med (2013) 4.15
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell (2010) 4.01
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
(S)NO signals: translocation, regulation, and a consensus motif. Neuron (1997) 3.67
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2006) 3.59
Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett (2009) 3.48
Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res (2008) 3.27
Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci (2009) 3.22
The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature (2004) 3.18
The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem (1993) 3.18
Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes (2009) 3.17
Signal integration via PKR. Sci STKE (2001) 3.17
Retracted Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol (2011) 3.02
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J (2008) 2.97
Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab (2012) 2.96
Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut (2003) 2.70
The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des (2009) 2.65
Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J Exp Med (2012) 2.62
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med (2012) 2.60
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A (2010) 2.52
Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr (2008) 2.48
Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol (2007) 2.33
Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology (2005) 2.32
Intestinal nutrient transport in genetically obese mice. Am J Clin Nutr (1995) 2.31
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One (2012) 2.17
Energy balance in adrenalectomized ob/ob mice: effects of dietary starch and glucose. Am J Physiol (1988) 2.10
Retracted Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling. PLoS One (2010) 2.08
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A (2004) 2.08
Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One (2012) 2.06
Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol (2009) 2.06
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab (2008) 2.05
Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes (2002) 1.99
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol (2007) 1.96
Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology (2008) 1.91
S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes (2005) 1.91
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr (2009) 1.90
Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta (2010) 1.85
Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes (2006) 1.83
Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr (2010) 1.82
Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol (2008) 1.78
Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol (2009) 1.76
Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) (2006) 1.66
Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol (2006) 1.66
Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J (2000) 1.66
Modular structure of PACT: distinct domains for binding and activating PKR. Mol Cell Biol (2001) 1.59
Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol (2011) 1.55
Concern Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia (2012) 1.54
Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab (2008) 1.52
Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res (2005) 1.50
Retracted Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats. Diabetes (2011) 1.50
Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res (2007) 1.48
Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One (2010) 1.43